Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T14968 |
Cinanserin hydrochloride
SQ 10643 |
Influenza Virus; 5-HT Receptor | GPCR/G Protein; Microbiology/Virology; Neuroscience |
Cinanserin hydrochloride (SQ 10643) 是一种高亲和力拮抗剂,对 5-HT2 受体的Ki 值为 41 nM。它也是严重急性呼吸综合征冠状病毒的 3C 样蛋白酶抑制剂。 | |||
T5188 |
GC376 sodium
|
SARS-CoV | Microbiology/Virology |
GC376 sodium 是一种 3C 样蛋白酶 (3CLpro) 抑制剂,IC50 值范围为 0.49~4.35 μM。 | |||
T9351 |
Nirmatrelvir
|
SARS-CoV | Microbiology/Virology |
PF-07321332 是一种有效的口服活性 SARS-CoV 3CLPRO 抑制剂,对 SARS-CoV-2 病毒有针对性,可研究 COVID-19。它是一种胰蛋白酶样蛋白酶抑制剂,可抑制气道上皮钠通道功能。 | |||
T9458 |
PF-00835231
|
SARS-CoV | Microbiology/Virology |
PF-00835231 是一种 CoV-2 半胱氨酸 3C 样蛋白酶抑制剂,对 SARS CoV-2 和 SARS CoV-1 3CLpro 的 IC50 分别为 0.27 nM 和 4 nM。它用于抗 SARS-CoV-2/COVID-19 的研究。 | |||
T70564 |
NPI64
|
||
NPI64 is a broad-spectrum coronavirus protease inhibitor which inhibits viral 3C and 3C-like protease. | |||
T71817 |
CID-948801
|
||
CID-948801 is a novel 3C-like protease inhibitor of SARS-CoV-2. | |||
T68674 |
Vincapusine
|
||
Vincapusine is a natural inhibitor of 3C-like protease (3CLpro), targeting SARS-CoV-2 3CLpro, SARS-CoV 3CLpro and MERS-CoV 3CLpro. | |||
T60962 |
SARS-CoV-2-IN-18
|
||
SARS-CoV-2-IN-18 (Compound 26) 是 SARS-CoV-2 3C-样蛋白酶的有效抑制剂 (IC50 = 45 nM)。 | |||
T72671 | SARS-CoV-2-IN-12 | ||
SARS-CoV-2-IN-12 是一种有效的 SARS-CoV-2相关 3C 样蛋白酶抑制剂 (Ki=32.1 pM),可用于预防 SARS-CoV-2 病毒复制,用于 COVID-19 的研究。 | |||
T79866 |
Zevotrelvir
|
SARS-CoV | Microbiology/Virology |
Zevotrelvir (化合物 52)作为冠状病毒抑制剂,对229E hCoV及SARS-CoV-3CL proteases展现出的IC50值均为 <0.1 μM和 <0.1 mM。此化合物显示了对病毒感染治疗的潜在应用。 | |||
T72364 | SARS-CoV-2 3CLpro-IN-5 | SARS-CoV | Microbiology/Virology |
SARS-CoV-2 3CLpro-IN-5 是一种针对 3C样蛋白酶3CLpro 的共价抑制剂,其抑制活性的 IC50 为 3.8 nM。该化合物的口服生物利用度(BA)为 9.0%,可用于 COVID-19 研究。 | |||
T40341 | SARS-CoV-2-IN-11 | ||
SARS-CoV-2-IN-11 is a highly potent and non-toxic inhibitor of the 3C-like protease (3CLpro) of SARS-CoV-2, demonstrating IC50 and EC50 values of 0.17 nM and 1.45 nM, respectively. This compound targets the essential viral replication enzyme, 3CLpro, making it an attractive candidate for intervention strategies. SARS-CoV-2-IN-11 holds significant promise in the development of specific antivirals against SARS-CoV-2. | |||
T40340 |
SARS-CoV-2-IN-10
|
||
SARS-CoV-2-IN-10 is a powerful and non-toxic inhibitor of SARS-CoV-2 3CL protease, with IC50 and EC50 values of 0.13 nM and 1.03 nM, respectively. The SARS-CoV-2 3C-like protease (3CLpro) is a critical enzyme for viral replication and serves as an ideal target for intervention. By targeting the SARS-CoV-2 3CL protease, SARS-CoV-2-IN-10 has the potential to facilitate the development of effective antiviral drugs specific to SARS-CoV-2. | |||
T83719 |
Mca-AVLQSGFR-K(Dnp)-K-NH2 TFA
|
||
Mca-AVLQSGFR-K(Dnp)-K-NH2 是针对严重急性呼吸综合征冠状病毒(SARS-CoV)主蛋白酶(Mpro),也称为3C样蛋白酶(3CLpro)的荧光底物。SARS-CoV Mpro 切割后,会释放7-甲氧基香豆素-4-乙酰基(Mca),通过其荧光可以量化SARS-CoV Mpro 活性。Mca 的激发/发射波长最大值分别为328/420 nm。 |